Patient and caregiver engagement in the Patient-Centered Outcomes Research Institute (PCORI) Health Care Horizon Scanning System (HCHSS) process.

OBJECTIVE: The Patient-Centered Outcomes Research Institute (PCORI) horizon scanning system is an early warning system for healthcare interventions in development that could disrupt standard care. We report preliminary findings from the patient engagement process. METHODS: The system involves broadly scanning many resources to identify and monitor interventions up to 3 years before anticipated entry into U.S. health care. Topic profiles are written on included interventions with late-phase trial data and circulated with a structured review form for stakeholder comment to determine disruption potential. Stakeholders include patients and caregivers recruited from credible community sources. They view an orientation video, comment on topic profiles, and take a survey about their experience. RESULTS: As of March 2020, 312 monitored topics (some of which were archived) were derived from 3,500 information leads; 121 met the criteria for topic profile development and stakeholder comment. We invited fifty-four patients and caregivers to participate; thirty-nine reviewed at least one report. Their perspectives informed analyst nominations for fourteen topics in two 2019 High Potential Disruption Reports. Thirty-four patient stakeholders completed the user-experience survey. Most agreed (68 percent) or somewhat agreed (26 percent) that they were confident they could provide useful comments. Ninety-four percent would recommend others to participate. CONCLUSIONS: The system has successfully engaged patients and caregivers, who contributed unique and important perspectives that informed the selection of topics deemed to have high potential to disrupt clinical care. Most participants would recommend others to participate in this process. More research is needed to inform optimal patient and caregiver stakeholder recruitment and engagement methods and reduce barriers to participation.

Case studies on forecasting for innovative technologies: frequent revisions improve accuracy.

Health technology forecasting is designed to provide reliable predictions about costs, utilization, diffusion, and other market realities before the technologies enter routine clinical use. In this article we address three questions central to forecasting's usefulness: Are early forecasts sufficiently accurate to help providers acquire the most promising technology and payers to set effective coverage policies? What variables contribute to inaccurate forecasts? How can forecasters manage the variables to improve accuracy? We analyzed forecasts published between 2007 and 2010 by the ECRI Institute on four technologies: single-room proton beam radiation therapy for various cancers; digital breast tomosynthesis imaging technology for breast cancer screening; transcatheter aortic valve replacement for serious heart valve disease; and minimally invasive robot-assisted surgery for various cancers. We then examined revised ECRI forecasts published in 2013 (digital breast tomosynthesis) and 2014 (the other three topics) to identify inaccuracies in the earlier forecasts and explore why they occurred. We found that five of twenty early predictions were inaccurate when compared with the updated forecasts. The inaccuracies pertained to two technologies that had more time-sensitive variables to consider. The case studies suggest that frequent revision of forecasts could improve accuracy, especially for complex technologies whose eventual use is governed by multiple interactive factors.

Post-endovascular aneurysm repair patient outcomes and follow-up are not adversely impacted by long travel distance to tertiary vascular surgery centers.

BACKGROUND: To determine whether patient adherence to follow-up and patient outcomes after endovascular aneurysm repair (EVAR) are affected by the distance between a patient's residence and a tertiary care treatment center. METHODS: A retrospective review of 136 consecutive patients undergoing EVAR at the New Mexico Veterans Affairs Medical Center over a 7-year period was conducted. Patients were stratified as living within a 100-mi radius of the treatment center (group 1) and those living outside this radius (group 2). Follow-up included clinic visits and computed tomography scans at 1 month after discharge, every 6 months for 2 years, and then yearly. Incomplete follow-up was defined if two or more consecutive appointments were missed. Survival and graft-related complication rates were analyzed for both the patient groups. RESULTS: Of the 136 patients, 10 patients died from nonaneurysm-related causes less than 1 year after their EVAR procedures, and hence were not a part of the study. Of the surviving patients, 44% lived within a 100-mi radius of the treatment center (group 1), and 56% outside this 100-mi radius (group 2). The mean patient follow-up time was 52.1 ± 25.9 months. Of the surviving patients, 15% had inadequate follow-up, yet there was no significant difference in the adequacy of follow-up for patients in group 1 compared with group 2. The incidence of major complications, defined as aneurysm rupture, conversion to open repair, myocardial infarction, and stroke, was not statistically different in group 1 versus group 2 (5.0% vs. 11.8%, p = 0.23). Of the five patients (3.7%) who died as a result of abdominal aortic aneurysms related causes, three were in group 1 and two in group 2. CONCLUSIONS: Distance from a tertiary care center is not a limiting factor in patient adherence to follow-up, patient graft-related morbidity, or patient survival, likely because of the Albuquerque VA Medical Center's electronic tracking of patients and provision of travel vouchers.

Top technology issues for ambulatory care facilities this year and beyond.

ECRI Institute medical technology experts (i.e., biomedical engineers, patient safety experts, physicians, and research scientists) compiled a list of important technology-related issues that executives and clinical leaders at ambulatory care facilities should pay close attention to this year. The list presents several high-profile technologies in the context of the convergence of critical economic, patient safety, reimbursement, and regulatory pressures. Guidance is provided about key considerations regarding adoption and implementation of electronic medical records, high-end computed tomography and magnetic resonance imaging technology, the convergence of health information technology and medical technologies highlighting integrated patient alarm systems as a case in point, physician preference items such as cardiac stents, robotic-assisted technology for minimally invasive procedures, image-guided radiation technologies, and the role of radiofrequency identification technology.

The naturalist approach - abstract

The primary role of the naturalist is to focus on energy-giving foods. He or she acts as an educator or dietary facilitator to advise interested patients on holistic management adaptation to the necessary changes in dietary lifestyle, and the importance on non-polluted environs. The naturalist, aware of this energy life force, works with plants and other organic substances linking plant life directly to the free energy conductivity of the air. Scientists have discovered chlorophyll as the engine of life. Wholistic methods - the macrobiotic approach to diabetes mellitus aims at restoring the capacity of the beta cells to produce insulin by restoring them to a more normal condition. This is accomplished by making a patient's diet comprise at least 60 percent cereal grains, 25 percent sauteed vegetables and 15 percent beans accompanied with moderate physical exercises. Reflexology, massages and acupressure are techniques introduced into the western world for free energy conductivity, and circulatory stimulation. These modalities are very effective in stabilizing the healthiness of diabetics. Vitamin deficiency contributes to degeneration in this disease, and others. It has been found that magnesium is always at low levels in diabetics, which is an important mineral to a diabetic's well-being. Vitamin B6 and zinc, control or reverse the altered metabolism in diabetes mellitus and vitamin B 12 and folic acid are involved in lipid and carbohydrate metabolism. Lecithin is excellent for the cell membrane, and helps to clean up excess of cholesterol in the blood system. Scientists are on the treshold of new developments on medicinal plants and biotechnology and major break-throughs are being made on specific plants that do reduce blood sugar levels (AU)